Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
A large UK cohort study found that influenza vaccination was tied to a 39% lower risk of flu-related hospitalization in COPD patients. But vaccinated patients also showed a 17% lower risk of urinary tract infections — a condition the flu shot has no biological reason to prevent — raising important questions about residual confounding in the data.
A new study published in Clinical Microbiology and Infection found that flu vaccination was associated with a 39% lower risk of influenza-related hospitalization among COPD patients in England over six flu seasons. Researchers analyzed over 56,000 matched pairs of vaccinated and unvaccinated COPD patients, finding that vaccinated individuals also had lower rates of severe exacerbations and pneumonia during epidemic periods — but not during the off-season, which adds some reassuring specificity to the findings.
However, the results come with an important caveat. Vaccinated patients also showed a 17% lower risk of urinary tract infections — a negative control outcome with no plausible biological link to the flu vaccine. This suggests that residual confounding (i.e., healthier or more health-conscious patients being more likely to get vaccinated) may be inflating the apparent benefits of vaccination.
By the Numbers:
Why it matters: This study highlights a key methodological challenge in vaccine effectiveness research — apparent benefits may partly reflect who gets vaccinated, not just the vaccine itself. Researchers are calling for negative control outcomes to become standard practice in future cohort studies to better detect and account for bias.
